Product Information

ENOXAPARIN 40 MG/0.4 ML SYR is a generic product labeled by Sanofi-Aventis U.S. LLC, priced at $6.9572 per ML under NDC 00955100410. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Mar 29, 1993. Its Orange Book therapeutic-equivalence code is AP.

The High Outlier badge above means this manufacturer's average price in the enoxaparin sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ENOXAPARIN 40 MG/0.4 ML SYR

enoxaparin sodium
$6.9572per ML
High Outlier

Strength

40 mg/.4mL

NDC

00955100410

Classification

Generic

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

ENOXAPARIN SODIUM

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020164

FDA Approved

3/29/1993

TE Code

AP

On Market Since

10/3/2011

Pharmacological Classes

Heparin
Low-Molecular-Weight
Low Molecular Weight Heparin

Price Statistics

The NADAC for ENOXAPARIN 40 MG/0.4 ML SYR has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 81.8%. The table below summarizes its recorded NADAC range and movement.

Current price$6.9572 per ML
All-time high$40.2380 (Jan 15, 2014)
All-time low$6.9572 (Nov 18, 2026)
52-week high$8.3504
52-week low$6.9572
Median price$12.3921
Average price$14.7695
Largest weekly change-25.0% (Aug 19, 2015)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-6.9%

1M

-10.6%

3M

-14.4%

6M

-12.8%

1Y

-20.9%

3Y

-33.2%

5Y

-47.4%

All

-81.8%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ENOXAPARIN 40 MG/0.4 ML SYR?

The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 40 MG/0.4 ML SYR, manufactured by Sanofi-Aventis U.S. LLC, is $6.9572 per ML (NDC 00955100410), effective Nov 18, 2026.

How has the price of ENOXAPARIN 40 MG/0.4 ML SYR changed over time?

Over the history we have for it, the NADAC for ENOXAPARIN 40 MG/0.4 ML SYR has declined 81.8%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ENOXAPARIN 40 MG/0.4 ML SYR?

Since Nov 28, 2013, the NADAC for ENOXAPARIN 40 MG/0.4 ML SYR has ranged from a low of $6.9572 (Nov 18, 2026) to a high of $40.2380 (Jan 15, 2014), with a median of $12.3921 per ML.

Are there cheaper alternatives to ENOXAPARIN 40 MG/0.4 ML SYR?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOVENOX 40 MG/0.4 ML SYRINGE, is $6.7750 per ML — about 3% below ENOXAPARIN 40 MG/0.4 ML SYR.

Who manufactures ENOXAPARIN 40 MG/0.4 ML SYR?

ENOXAPARIN 40 MG/0.4 ML SYR (NDC 00955100410) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a generic product.